Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Avantor, Inc.    AVTR

AVANTOR, INC.

(AVTR)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
11/23/2020 11/24/2020 11/25/2020 11/27/2020 11/30/2020 Date
25.9(c) 25.96(c) 26.04(c) 26.35(c) 27.28(c) Last
6 041 484 2 078 365 2 855 829 1 041 581 7 544 822 Volume
-0.08% +0.23% +0.31% +1.19% +3.53% Change
More quotes
Financials (USD)
Sales 2020 6 223 M - -
Net income 2020 168 M - -
Net Debt 2020 4 603 M - -
P/E ratio 2020 99,6x
Yield 2020 0,13%
Sales 2021 6 650 M - -
Net income 2021 416 M - -
Net Debt 2021 3 911 M - -
P/E ratio 2021 39,9x
Yield 2021 0,07%
Capitalization 15 777 M 15 777 M -
EV / Sales 2020 3,27x
EV / Sales 2021 2,96x
Nbr of Employees -
Free-Float 85,8%
More Financials
Company
Avantor, Inc. is a global provider of mission critical products and services. Its products include materials and consumables, equipment and instrumentation, and services and specialty procurement. Materials and consumables includes chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and... 
More about the company
Notations Surperformance© of Avantor, Inc.
Trading Rating : Investor Rating :
More Ratings
All news about AVANTOR, INC.
11/23AVANTOR : reg; to Participate at the Evercore ISI 3rd Annual HealthCONx Virtual ..
PR
11/19AVANTOR : reg; Opens New Biorepository Facility in Europe to Support Growing Dem..
PR
11/11AVANTOR : reg; to Present at the Jefferies Virtual London Healthcare Conference
PR
11/10AVANTOR, INC. : Entry into a Material Definitive Agreement, Financial Statements..
AQ
11/06AVANTOR, INC. : Entry into a Material Definitive Agreement, Termination of a Mat..
AQ
11/05AVANTOR : reg; Announces Pricing of Upsized Secondary Offering
PR
11/04AVANTOR : reg; Announces Secondary Offering of 71,339,001 Shares of Common Stock
PR
11/02AVANTOR : reg; Discusses Cell & Gene Therapy Production Trends Through the Lens ..
AQ
11/02AVANTOR : reg; Discusses Cell & Gene Therapy Production Trends Through the Lens ..
PR
10/30AVANTOR, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
10/30AVANTOR : reg; Announces Upsizing and Pricing of Offering of €650.0 Million of S..
PR
10/28AVANTOR, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
10/28AVANTOR : reg; Announces Offering of Senior First Lien Notes
PR
10/27AVANTOR : Management's discussion and analysis of financial condition and result..
AQ
10/27AVANTOR, INC. : Results of Operations and Financial Condition (form 8-K)
AQ
More news
News in other languages on AVANTOR, INC.
02/04AVANTOR, INC. : publication des résultats annuels
02/04AVANTOR, INC. : Veröffentlichung des Jahresergebnisses
More news
Chart AVANTOR, INC.
Duration : Period :
Avantor, Inc. Technical Analysis Chart | AVTR | US05352A1007 | MarketScreener
Technical analysis trends AVANTOR, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 20
Average target price 28,06 $
Last Close Price 27,28 $
Spread / Highest target 21,0%
Spread / Average Target 2,84%
Spread / Lowest Target -23,0%
EPS Revisions
Managers
NameTitle
Michael Stubblefield President, Chief Executive Officer & Director
Rajiv Lochan Gupta Chairman
Bjorn Hofman Chief Operating Officer & Executive Vice President
Thomas A. Szlosek Chief Financial Officer & Executive VP
Ashish K. Kulkarni Chief Technology Officer & Executive VP
Sector and Competitors
1st jan.Capitalization (M$)
AVANTOR, INC.50.30%15 777
ABBOTT LABORATORIES24.59%191 805
MEDTRONIC PLC0.22%152 480
BECTON, DICKINSON AND COMPANY-13.65%68 111
HOYA CORPORATION33.11%49 894
BAXTER INTERNATIONAL INC.-9.03%38 858